Merrimack Pharmaceuticals, Inc. EBITDA Margin 2010-2024 | MACK

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Merrimack Pharmaceuticals, Inc. (MACK) over the last 10 years. The current EBITDA margin for Merrimack Pharmaceuticals, Inc. as of March 31, 2024 is .
EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2015-09-30 $0.10B $-0.09B -86.27%
2015-06-30 $0.11B $-0.08B -65.79%
2015-03-31 $0.11B $-0.07B -66.67%
2014-12-31 $0.10B $-0.06B -62.14%
2014-09-30 $0.08B $-0.09B -112.99%
2014-06-30 $0.06B $-0.10B -176.79%
2014-03-31 $0.05B $-0.11B -247.83%
2013-12-31 $0.05B $-0.12B -245.83%
2013-09-30 $0.05B $-0.11B -211.11%
2013-06-30 $0.06B $-0.10B -175.86%
2013-03-31 $0.05B $-0.09B -178.85%
2012-12-31 $0.05B $-0.09B -185.42%
2012-09-30 $0.05B $-0.08B -174.47%
2012-06-30 $0.05B $-0.08B -168.89%
2012-03-31 $0.04B $-0.09B -212.50%
2011-12-31 $0.04B $-0.08B -214.29%
2011-09-30 $0.03B $-0.05B -185.71%
2011-06-30 $0.03B $-0.03B -116.00%
2011-03-31 $0.02B $0.00B 13.64%
2010-12-31 $0.02B $0.02B 100.00%